Independence

Avalon Cyprus Estate Launches Expansion Into China and South Korea

Retrieved on: 
Wednesday, April 17, 2024
Beauty, CIS, Independence, Commonwealth, Communication, Language, Growth, Republic, Financial services

Nicosia, Cyprus--(Newsfile Corp. - April 16, 2024) - Avalon Cyprus Estate, a prominent player in the Republic of Cyprus and the Turkish Republic of Cyprus real estate management market, has unveiled an ambitious plan to expand its operations into two major Asian markets: China and South Korea.

Key Points: 
  • Nicosia, Cyprus--(Newsfile Corp. - April 16, 2024) - Avalon Cyprus Estate, a prominent player in the Republic of Cyprus and the Turkish Republic of Cyprus real estate management market, has unveiled an ambitious plan to expand its operations into two major Asian markets: China and South Korea.
  • "We are thrilled to introduce Avalon's expertise and personalized approach to the discerning clientele in China and South Korea," shared a spokesperson for Avalon Cyprus Estate.
  • The expansion into China and South Korea underscores Avalon's unwavering dedication to growth and its commitment to catering to a global audience.
  • The expansion into China and South Korea marks a significant milestone for Avalon Cyprus Estate.

Growth Opportunities in the Polyurethane Market - PUs for EV Applications, Reshoring to MEASA, Partnerships in 5G Infrastructure, Healthcare Applications, Circular Economy Initiatives and 3D Printing - ResearchAndMarkets.com

Retrieved on: 
Monday, March 18, 2024
Chemicals, Plastics, Manufacturing, European Economic Area, Growth, Independence, European Free Trade Association, PU, Commonwealth

This region demonstrates diverse market dynamics, with the United States leading in consumption and innovation.

Key Points: 
  • This region demonstrates diverse market dynamics, with the United States leading in consumption and innovation.
  • The region's focus on sustainability and the development of eco-friendly PU variants are key factors influencing market growth.
  • The global PU market is poised for robust growth, with each region contributing uniquely to the industry's expansion.
  • This study offers valuable insights for stakeholders, investors, and industry participants, helping them make informed decisions in a dynamic and evolving market.

Meriwest Credit Union Introduces SMART Start Checking for Youth, Empowering Financial Independence

Retrieved on: 
Tuesday, February 20, 2024
Online, Marketing, Meriwest Credit Union, Parent, Direct deposit, Parental controls, Credit union, Independence, Child, Financial management, Ageing, Bank

SILICON VALLEY, Calif., Feb. 20, 2024 (GLOBE NEWSWIRE) -- Meriwest Credit Union has announced the launch of the SMART Start Checking Account, tailored specifically for youth aged 9 to 17.

Key Points: 
  • SILICON VALLEY, Calif., Feb. 20, 2024 (GLOBE NEWSWIRE) -- Meriwest Credit Union has announced the launch of the SMART Start Checking Account, tailored specifically for youth aged 9 to 17.
  • Independence is encouraged with the SMART Start Checking Account, eliminating the need for teens to rely on their parents' credit cards or carry cash.
  • The SMART Start Checking Account is designed to instill smart financial habits and promote independence from an early age.
  • To learn more about the SMART Start Checking Account and how it can help your child develop a strong foundation for financial success, visit www.meriwest.com , stop by a financial center, or contact Meriwest Credit Union at 877-637-4937.

Dragos OT Cybersecurity “Year in Review” Reports Rise in Geopolitically Driven Attacks, Ransomware, and Threat Groups

Retrieved on: 
Tuesday, February 20, 2024
Software, Technology, Data Management, Security, Internet, Necessity and sufficiency, Research, Commonwealth, POC, Aviation, Stage 2, Government, Rockwell Automation, Independence, Hacktivism, OT, Organization, ICS, Telecommunications, Denial-of-service attack, Environment, Inc., Separate, Oracle Applications, Arms industry

Dragos Inc., the global leader in cybersecurity for operational technology (OT) environments, today released its sixth annual Dragos OT Cybersecurity Year in Review report, the most comprehensive report on cyber threats facing industrial organizations.

Key Points: 
  • Dragos Inc., the global leader in cybersecurity for operational technology (OT) environments, today released its sixth annual Dragos OT Cybersecurity Year in Review report, the most comprehensive report on cyber threats facing industrial organizations.
  • “OT cyber threats reached a tipping point in 2023,” said Robert M. Lee, co-founder and CEO of Dragos.
  • With these additions, Dragos analysts now track 21 Threat Groups worldwide that have been observed as being engaged in OT operations in 2023.
  • The 2023 Dragos OT Cybersecurity Year in Review is an annual overview and analysis of OT-focused global threat activities, vulnerabilities, and industry insights and trends.

Numerous Amici Join NCLA’s Ask for Supreme Court to Rule Against ATF’s Unilateral Bump Stock Ban

Retrieved on: 
Friday, February 2, 2024
Firearm, Buckeye Institute, National Shooting Sports Foundation, Policy, Education, Independence, Congress, Army, Supreme court, Independence Institute, Philip Van Cleave, Rule, Research, Bureau, Tobacco, The Final Rule, National Rifle Association, Fifth, Second, Pacific Legal Foundation, NCLA, Machine, Judge, Ambiguity, Court, Palmetto State Armory, National Association

Representing Texas gun shop owner and Army veteran Michael Cargill, NCLA challenges the Bureau of Alcohol, Tobacco, Firearms and Explosives’ Bump Stock Final Rule and ATF’s expansion of the criminal scope of a statute by administrative fiat.

Key Points: 
  • Representing Texas gun shop owner and Army veteran Michael Cargill, NCLA challenges the Bureau of Alcohol, Tobacco, Firearms and Explosives’ Bump Stock Final Rule and ATF’s expansion of the criminal scope of a statute by administrative fiat.
  • The Final Rule reversed ATF’s long-standing recognition that bump-stock-equipped firearms are not illegal machine guns, and the U.S. Court of Appeals for the Fifth Circuit rightly shot down the Rule early last year.
  • NCLA thanks the amicus parties for standing with Mr. Cargill and thousands of other legal purchasers of bump stocks.
  • Excerpts follow:
    “In the best tradition of our separation of powers jurisprudence, this Court should apply the criminal laws that Congress has written with unmistakable clarity.

Venatorx Pharmaceuticals and Menarini Group Enter Commercial Agreement for Cefepime-Taniborbactam in 96 Countries

Retrieved on: 
Tuesday, January 9, 2024
Health, Clinical Trials, Research, Pharmaceutical, Science, Biotechnology, Commonwealth, Patient, CIS, Medicine, Infection, Medication, Independence, AMR, Pharmaceutical industry

Venatorx Pharmaceuticals, a private, pre-commercial pharmaceutical company focused on improving health outcomes for patients with multidrug-resistant bacterial infections and hard-to-treat viral infections, and Menarini Group, an Italian biopharmaceutical group, today announced that they have entered into an agreement under which Menarini will acquire the exclusive rights to commercialize, upon approval of relevant health authorities, cefepime-taniborbactam in 96 countries in Europe, Latin America, Middle East, Turkey and North Africa and the Commonwealth of Independent States (CIS).

Key Points: 
  • Venatorx Pharmaceuticals, a private, pre-commercial pharmaceutical company focused on improving health outcomes for patients with multidrug-resistant bacterial infections and hard-to-treat viral infections, and Menarini Group, an Italian biopharmaceutical group, today announced that they have entered into an agreement under which Menarini will acquire the exclusive rights to commercialize, upon approval of relevant health authorities, cefepime-taniborbactam in 96 countries in Europe, Latin America, Middle East, Turkey and North Africa and the Commonwealth of Independent States (CIS).
  • Under the terms of the agreement, Venatorx will receive an upfront licensing fee, additional R&D, regulatory, and sales-based milestone payments, and potential royalty payments based on a percentage of net sales.
  • “With its global commercial infrastructure and significant experience in commercializing infectious disease products, including antibiotics, Menarini is ideally positioned to bring cefepime-taniborbactam to key geographic markets,” said Christopher J. Burns, Ph.D., Chief Executive Officer of Venatorx.
  • “By leveraging our expertise and Menarini’s expansive commercial infrastructure, we will provide the resources needed to optimize the commercialization, upon approval of relevant health authorities, of cefepime-taniborbactam and ensure patient access to this medicine across our global footprint.”

Sanctuary Wealth Taps Veteran Industry Executive Laurie Burkhard to Head New Business Consulting Division

Retrieved on: 
Wednesday, January 10, 2024
Learning, Head, Mike Adam, Ecosystem, Royal Bank of Canada, Practice management, Independence, Business consultant, Management

INDIANAPOLIS, Jan. 10, 2024 /PRNewswire/ -- Sanctuary Wealth (Sanctuary), home to the next generation of elite advisors, has announced the appointment of former RBC Wealth Management senior leader Laurie Burkhard as a Director and Head of Business Consulting, a newly created division. Ms. Burkhard will use her nearly three decades of experience to further enhance Sanctuary's business consulting and practice management offerings and build an industry leading division with the sole focus of helping affiliated independent advisors better grow and build enterprise value in their businesses.

Key Points: 
  • INDIANAPOLIS, Jan. 10, 2024 /PRNewswire/ -- Sanctuary Wealth (Sanctuary), home to the next generation of elite advisors, has announced the appointment of former RBC Wealth Management senior leader Laurie Burkhard as a Director and Head of Business Consulting, a newly created division.
  • "On behalf of our entire team, it's my true pleasure to welcome Laurie to Sanctuary as Head of Business Consulting," said Adam Malamed, CEO of Sanctuary Wealth.
  • "Over the course of her career, Laurie has built some of the most successful business consultant and practice management programs in the industry, leaving an indelible mark on the independent wealth management landscape.
  • "With Laurie onboard, business consulting will become a core value-added offering at Sanctuary," said Mr. Longley.

Venatorx Pharmaceuticals and Menarini Group Enter Commercial Agreement for Cefepime-Taniborbactam in 96 Countries

Retrieved on: 
Tuesday, January 9, 2024
Commonwealth, Patient, CIS, Medicine, Infection, Independence, AMR, Pharmaceutical industry

Under the terms of the agreement, Venatorx will receive an upfront licensing fee, additional R&D, regulatory, and sales-based milestone payments, and potential royalty payments based on a percentage of net sales.

Key Points: 
  • Under the terms of the agreement, Venatorx will receive an upfront licensing fee, additional R&D, regulatory, and sales-based milestone payments, and potential royalty payments based on a percentage of net sales.
  • "With its global commercial infrastructure and significant experience in commercializing infectious disease products, including antibiotics, Menarini is ideally positioned to bring cefepime-taniborbactam to key geographic markets," said Christopher J. Burns, Ph.D., Chief Executive Officer of Venatorx.
  • "At Menarini, we believe that the addition of cefepime-taniborbactam expands our existing AMR anti infectives portfolio and provides the opportunity to further strengthen our building of an important antibiotics portfolio focused on the critical pathogens responsible for the vast majority of antibiotic resistance" said Elcin Barker Ergun, CEO of the Menarini Group.
  • "By leveraging our expertise and Menarini's expansive commercial infrastructure, we will provide the resources needed to optimize the commercialization, upon approval of relevant health authorities, of cefepime-taniborbactam and ensure patient access to this medicine across our global footprint."

Venatorx Pharmaceuticals and Menarini Group Enter Commercial Agreement for Cefepime-Taniborbactam in 96 Countries

Retrieved on: 
Tuesday, January 9, 2024
Commonwealth, Patient, CIS, Medicine, Infection, Independence, AMR, Pharmaceutical industry

Under the terms of the agreement, Venatorx will receive an upfront licensing fee, additional R&D, regulatory, and sales-based milestone payments, and potential royalty payments based on a percentage of net sales.

Key Points: 
  • Under the terms of the agreement, Venatorx will receive an upfront licensing fee, additional R&D, regulatory, and sales-based milestone payments, and potential royalty payments based on a percentage of net sales.
  • "With its global commercial infrastructure and significant experience in commercializing infectious disease products, including antibiotics, Menarini is ideally positioned to bring cefepime-taniborbactam to key geographic markets," said Christopher J. Burns, Ph.D., Chief Executive Officer of Venatorx.
  • "At Menarini, we believe that the addition of cefepime-taniborbactam expands our existing AMR anti infectives portfolio and provides the opportunity to further strengthen our building of an important antibiotics portfolio focused on the critical pathogens responsible for the vast majority of antibiotic resistance" said Elcin Barker Ergun, CEO of the Menarini Group.
  • "By leveraging our expertise and Menarini's expansive commercial infrastructure, we will provide the resources needed to optimize the commercialization, upon approval of relevant health authorities, of cefepime-taniborbactam and ensure patient access to this medicine across our global footprint."

Amplitude Strengthens International Investment with New Regional Leaders

Retrieved on: 
Thursday, January 4, 2024
Software, Technology, Networks, Data Management, Carbon, Samsung Telecommunications, HP, Microsoft, VMware Carbon Black, IBM Consulting, UiPath, Apple, APJ, Independence, Commonwealth, Analytics, Growth, Lifecell, MobileIron

We have a unique opportunity at Amplitude to help fuel that growth with data, insights and actions that can improve digital experiences,” said Nate Crook, Amplitude’s Chief Revenue Officer.

Key Points: 
  • We have a unique opportunity at Amplitude to help fuel that growth with data, insights and actions that can improve digital experiences,” said Nate Crook, Amplitude’s Chief Revenue Officer.
  • “Amplitude exists to help companies build better products through data, and ultimately, drive growth.
  • Before joining Amplitude, he led emerging markets at UiPath, managing operations in more than 100 countries.
  • “Amplitude has a fantastic reputation for helping businesses leverage data and insights to improve their digital experiences, deepen customer relationships, and drive growth.